Proliferation inhibition, DNA damage, and cell-cycle arrest of human astrocytoma cells after acrylamide exposure

Chemical Research in Toxicology

Volumn 23, Issue 9, 2010, Pages 1449-1458

  Chen, Jong Hang ^a   Tsou, Tsui Chun ^b   Chiu, Ing Ming ^b,c   Chou, Chin Cheng ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; ATM PROTEIN; CAFFEINE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; DNA; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ARTICLE; ASTROCYTOMA CELL; ATAXIA TELANGIECTASIA; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA DETERMINATION; EVALUATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MOLECULE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACRYLAMIDE; ASTROCYTES; ASTROCYTOMA; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; COMET ASSAY; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA-BINDING PROTEINS; G0 PHASE; G1 PHASE; HUMANS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; ATAXIA TELANGIECTASIA;

EID: 77956909003     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx1000893     Document Type: Article

References (56)

1. Rice, J. M. (2005) The carcinogenicity of acrylamide Mutat. Res. 580, 3-20
2. Swedish National Food Administration (SNFA) (2002) Acrylamide Is Formed during the Preparation of Food and Occurs in Many Foodstuffs, Swedish National Food Administration: Uppsala, Sweden, www.slv.se.
3. FAO/WHO (2002) FAO/WHO Consultation on the Health Implications of Acrylamide in Food, June 25-27. Summary Report, http://www.who.int/foodsafety/ publications/chem/en/acrylamide-summary.pdf.
4. Kutting, B., Schettgen, T., Schwegler, U., Fromme, H., Uter, W., Angerer, J., and Drexler, H. (2009) Acrylamide as environmental noxious agent: a health risk assessment for the general population based on the internal acrylamide burden Int. J. Hyg. Environ. Health 212, 470-480
5. International Agency for Research on Cancer (IARC) (1994) Acrylamide, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Industrial Chemicals, Vol. 60, pp 389-433, IARC, Lyon, France.
6. Johnson, K. A., Gorzinski, S. J., Bodner, K. M., Campbell, R. A., Wolf, C. H., Friedman, M. A., and Mast, R. W. (1986) Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats Toxicol. Appl. Pharmacol. 85, 154-168
7. Friedman, M. A., Dulak, L. H., and Stedham, M. A. (1995) A lifetime oncogenicity study in rats with acrylamide Fundam. Appl. Toxicol. 27, 95-105
8. Hogervorst, J. G. F., Schouten, L. J., Konings, E. J. M., Goldbohm, R. A., and van den Brandt, P. A. (2009) Dietary acrylamide intake and brain cancer risk Cancer Epidemiol. Biomarkers Prev. 18, 1663-1666
9. Okuno, T., Matsuoka, M., Sumizawa, T., and Igisu, H. (2006) Involvement of the extracellular signal-regulated protein kinase pathway in phosphorylation of p53 protein and exerting cytotoxicity in human neuroblastoma cells (SH-SY5Y) exposed to acrylamide Arch. Toxicol. 80, 146-153
10. Sumizawa, T. and Igisu, H. (2007) Apoptosis induced by acrylamide in SH-SY5Y cells Arch. Toxicol. 81, 279-282
11. Hartley, C. L., Anderson, V. E., Anderton, B. H., and Robertson, J. (1997) Acrylamide and 2,5-hexanedione induce collapse of neurofilaments in SH-SY5Y human neuroblastoma cells to form perikaryal inclusion bodies Neuropathol. Appl. Neurobiol. 23, 364-372
12. Nakagawa-Yagi, Y., Choi, D. K., Ogane, N., Shimada, S. I., Seya, M., Momoi, T., Ito, T., and Sakaki, Y. (2001) Discovery of a novel compound: insight into mechanisms for acrylamide-induced axonopathy and colchicines-induced apoptotic neuronal cell death Brain Res. 909, 8-19
13. Aschner, M., Cao, C., Wu, Q., and Friedman, M. A. (2003) The acute effects of acrylamide on astrocyte functions Ann. N.Y. Acad. Sci. 993, 296-304
14. Aschner, M., Wu, Q., and Friedman, M. A. (2005) Effects of acrylamide on primary neonatal rat astrocyte functions Ann. N.Y. Acad. Sci. 1053, 444-454
15. Cookson, M. R. and Pentreath, V. W. (1994) Alterations in the glial fibrillary acidic protein content of primary astrocyte cultures for evaluation of glial cell toxicity Toxicol. in Vitro 8, 351-359
16. Holden, L. J. and Coleman, M. D. (2007) Assessment of the astrogliotic responses of three human astrocytoma cell lines to ethanol, trimethyltin chloride and acrylamide Toxicology 241, 75-83
17. Chen, J. H., Wu, K. Y., Chiu, I. M., Tsou, T. C., and Chou, C. C. (2009) Acrylamide-induced astrogliotic and apoptotic responses in human astrocytoma cells Toxicol. in Vitro 23, 855-861
18. Barres, B. A. (1991) New roles for glia J. Neurosci. 11, 3685-3694
19. Gomes, F. C. A., Paulin, D., and Neto, M. V. (1999) Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation Braz. J. Med. Biol. Res. 32, 619-631
20. Lahdetie, J., Suutari, A., and Sjoblom, T. (1994) The spermatid micronucleus test with the dissection technique detects the germ cell mutagenicity of acrylamide in rat meiotic cells Mutat. Res. 309, 255-262
21. Puppel, N., Tjaden, Z., Fueller, F., and Marko, D. (2005) DNA strand breaking capacity of acrylamide and glycidamide in mammalian cells Mutat. Res. 580, 71-80
22. Chico Galdo, V., Massart, C., Jin, L., Vanvooren, V., Caillet-Fauquet, P., Andry, G., Lothaire, P., Dequanter, D., Friedman, M., and Van, S. J. (2006) Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures Mol. Cell. Endocrinol. 257, 6-14
23. Koyama, N., Sakamoto, H., Sakuraba, M., Koizumi, T., Takashima, Y., Hayashi, M., Matsufuji, H., Yamagata, K., Masuda, S., Kinae, N., and Honma, M. (2006) Genotoxicity of acrylamide and glycidamide in human lymphoblastoid TK6 cells Mutat. Res. 603, 151-158
24. Jiang, L., Cao, J., An, Y., Geng, C., Qu, S., Jiang, L., and Zhong, L. (2007) Genotoxicity of acrylamide in human hepatoma G2 (HepG2) cells Toxicol. in Vitro 21, 1486-1492 (Pubitemid 350089959)
25. Keith, C. T. and Schreiber, S. L. (1995) PIK-related kinase: DNA repair, recombination, and cell cycle checkpoints Science 270, 50-51
26. Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S. Y., Taya, Y., Prives, C., and Abraham, R. T. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53 Genes Dev. 13, 152-157
27. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division Cell 88, 323-331
28. Krona, A., Jarnum, S., Salford, L. G., Widegren, B., and Aman, P. (2005) Oncostatin M signaling in human glioma cell lines Oncol. Rep. 13, 807-811
29. Liu, Y., Ray, S. K., Yang, X. Q., Vera, L. L., and Chiu, I. M. (1998) A splice variant of E2-2 basic helix-loop-helix protein represses the brain-specific fibroblast growth factor 1 promoter through the binding to an imperfect E-box J. Biol. Chem. 273, 19269-19276
30. Myers, R. L., Ray, S. K., Eldridge, R., Chotani, M. A., and Chiu, I. M. (1995) Functional characterization of the brain-specific FGF-1 promoter, FGF-1.B J. Biol. Chem. 270, 8257-8266
31. Ray, S. K., Yang, X. Q., and Chiu, I. M. (1997) Transcriptional activation of fibroblast growth factor 1.B promoter is mediated through an 18-base pair cis -acting element J. Biol. Chem. 272, 7546-7555
32. KIP1) on malignant glioma cells Br. J. Cancer 88, 1277-1280
33. Scholzen, T. and Gerdes, J. (2000) The Ki-67 protein: from the known and the unknown J. Cell. Physiol. 182, 311-322
34. Blasina, A., Price, B. D., Turenne, G. A., and McGowan, C. H. (1999) Caffeine inhibits the checkpoint kinase ATM Curr. Biol. 9, 1135-1138
35. Sarkaria, J. N., Busby, E. C., Tibbetts, R. S., Roos, P., Taya, Y., Karnitz, L M., and Abraham, R. T. (1999) Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine Cancer Res. 59, 4375-4382
36. Zhang, X., Cao, J., Jiang, L., Geng, C., and Zhong, L. (2009) Protective effect of hydroxytyrosol against acrylamide-induced cytotoxicity and DNA damage in HepG2 cells Mutat. Res. 664, 64-68
37. Oliveira, N. G., Pingarilho, M., Martins, C., Fernandes, A. S., Vaz, S., Martins, V., Rueff, J., and Gaspar, J. F. (2009) Cytotoxicity and chromosomal aberrations induced by acrylamide in V79 cells: Role of glutathione modulators Mutat. Res. 676, 87-92
38. Kayaselcuk, F., Zorludemir, S., Gumurdulu, D., Zeren, H., and Erman, T. (2002) PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade J. Neuro-Oncol. 57, 115-121
39. Kordek, R., Biernat, W., Alwasiak, J., and Liberski, P. P. (1996) Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours Acta Neurochir. 138, 509-512
40. Torp, S. H. and Granli, U. S. (2001) Proliferative activity in human glioblastomas assessed by various techniques Acta Pathol. Microbiol. Immunol. Scand. 109, 865-869
41. Klaunig, J. E. (2008) Acrylamide carcinogenicity J. Agri. Food Chem. 56, 5984-5988
42. 14C]acrylamide Carcinogenesis 16, 1161-1165
43. Friedberg, E. C., Walker, G. C., and Siede, W. (1995) Base Excision Repair, in DNA Pepair and Mutagenesis (Friedberg, E. C., Walker, G. C., and Siede, W., Eds.) pp 135-190, American Society for Microbiology, Wshington, DC.
44. Martins, C., Oliveira, N. G., Pingarilho, M., Costa, G. G., Martins, V., Marques, M. M., Beland, F. A., Churchwell, M. I., Doerge, D. R., Rueff, J., and Gaspar, J. F. (2007) Cytogenetic damage induced by acrylamide and glycidamide in mammalian cells: correlation with specific glycidamide-DNA adducts Toxicol. Sci. 95, 383-390
45. Yang, J., Xu, Z. P., Huang, Y., Hamrick, H. E., Duerksen-Hughes, P. J., and Yu, Y. N. (2004) ATM and ATR: sensing DNA damage World J. Gastroenterol. 10, 155-160
46. Arellano, M. and Moreno, S. (1997) Regulation of CDK/cyclin complexes during the cell cycle Int. J. Biochem. Cell Biol. 29, 559-573
47. Nurse, P. (2000) A long twentieth century of the cell cycle and beyond Cell 100, 71-78
48. Sangfelt, O., Erickson, S., Castro, J., Heiden, T., Gustafsson, A., Stefan, E., and Grander, D. (1999) Molecular mechanisms underlying interferon-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins Oncogene 18, 2798-2810
49. 1-phase progression Genes Dev. 13, 1501-1512
50. Jiang, H., Lin, J., Su, Z., Collart, F. R., Huberman, E., and Fisher, P. B. (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53 Oncogene 9, 3397-3407
51. 2/M arrest in primary aortic endothelial cells Arch. Toxicol. 80, 804-810
52. Sriram, K., Benkovic, S. A., Hebert, M. A., Miller, D. B., and OCallaghan, J. P. (2004) Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration J. Biol. Chem. 279, 19936-19947
53. Germain, D. and Frank, D. A. (2007) Targeting the cytoplasmic and nuclear function of signal transducers and activators of transcription 3 for cancer therapy Clin. Cancer Res. 13, 5665-5669
54. Kip1, a cyclin-Cdk inhibitors, links transforming growth factor-β and contact inhibition to cell cycle arrest Genes Dev. 8, 9-22
55. Hickson, J., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., and Smith, G. C. M. (2004) Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM Cancer Res. 64, 9152-9159
56. Kramer-Hammerle, S., Rothenaigner, I., Wolff, H., Bell, J. E., and Brack-Werner, R. (2005) Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus Virus Res. 111, 194-213